AGREEMENTRegistration Rights Agreement • April 13th, 2004 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
NO. WA2-64 ISSUED: APRIL 19, 2004 A-2 WARRANT TO PURCHASE COMMON STOCK THIS CERTIFIES THAT, for good and valuable consideration, Franklin M. Berger (the "HOLDER") is entitled to purchase from Adventrx Pharmaceuticals, Inc., a Delaware corporation (the...Adventrx Pharmaceuticals Inc • May 12th, 2004 • Pharmaceutical preparations • California
Exhibit 4.23 SECURITIES PURCHASE AGREEMENT dated as of July 21, 2005,Securities Purchase Agreement • August 12th, 2005 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 4.27 THIS WARRANT HAS BEEN, AND THE SHARES OF COMMON STOCK WHICH MAY BE RECEIVED PURSUANT TO THE EXERCISE OF THIS WARRANT WILL BE, ACQUIRED SOLELY FOR INVESTMENT AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION...Adventrx Pharmaceuticals Inc • September 2nd, 2005 • Pharmaceutical preparations • California
BACKGROUNDRegistration Rights Agreement • June 30th, 2004 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 4.30 THIS WARRANT HAS BEEN, AND THE SHARES OF COMMON STOCK WHICH MAY BE RECEIVED PURSUANT TO THE EXERCISE OF THIS WARRANT WILL BE, ACQUIRED SOLELY FOR INVESTMENT AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION...Adventrx Pharmaceuticals Inc • September 2nd, 2005 • Pharmaceutical preparations • California
Exhibit 10.6 EXECUTIVE EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, made as of the 1st day of December, 1999, by and between Warren C. Lau (the "Executive"), an individual residing 16702 Tennison Court, Spring, Texas, 77379 and BioQuest, Inc. (the...Employment Agreement • October 2nd, 2001 • Biokeys Pharmaceuticals Inc • Delaware
RECITALSRegistration Rights Agreement • September 15th, 2004 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS WARRANT HAS BEEN, AND THE SHARES OF COMMON STOCK WHICH MAY BE RECEIVED PURSUANT TO THE EXERCISE OF THIS WARRANT WILL BE, ACQUIRED SOLELY FOR INVESTMENT AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION THEREOF. NEITHER...Adventrx Pharmaceuticals Inc • June 30th, 2004 • Pharmaceutical preparations • California
10.3 (REFILED) * PLEASE NOTE THAT CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED BASED ON A REQUEST FOR CONFIDENTIAL TREATMENT FILED WITH THE COMMISSION ALONG WITH THE INFORMATION REQUESTED TO BE OMITTED. OPTION AND LICENSE AGREEMENT 1....Agreement • January 14th, 2002 • Biokeys Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 4.27 May [15], 2005 PERSONAL AND CONFIDENTIAL ADVENTRX Pharmaceuticals, Inc. 6725 Mesa Ridge Rd., Suite 100 San Diego, CA 92121 Dear Evan: This letter agreement (this "Agreement") will confirm the understanding and agreement between CIBC World...Letter Agreement • August 12th, 2005 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • New York
21,000,000 Shares of Common Stock and Pre-Funded Warrants to Purchase 5,666,667 Shares of Common Stock Savara Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • July 13th, 2023 • Savara Inc • Pharmaceutical preparations • New York
EXHIBIT 4.26 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION...Adventrx Pharmaceuticals Inc • August 26th, 2005 • Pharmaceutical preparations
BACKGROUNDRights Agreement • August 12th, 2005 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • New York
FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • October 2nd, 2001 • Biokeys Pharmaceuticals Inc
COMMON STOCK PURCHASE WARRANT ADVENTRX PHARMACEUTICALS, INC.Common Stock Purchase Warrant • November 14th, 2011 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, , or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date, as listed above, and on or prior to the close of business on April 1, 2015 (the “Termination Date”) but not thereafter, to subscribe for and purchase from ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued by the Company as of the date hereof pursuant to (i) Section A.2 of the Engagement Letter Agreement, dated May 17, 2011, between the Company and Rodman & Renshaw, LLC and (ii) Section 4(2) of the Securities Act an
MAST THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIESIndenture • March 24th, 2015 • Mast Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [—], 20[—], among MAST THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
EXHIBIT 4.28 THIS WARRANT HAS BEEN, AND THE SHARES OF COMMON STOCK WHICH MAY BE RECEIVED PURSUANT TO THE EXERCISE OF THIS WARRANT WILL BE, ACQUIRED SOLELY FOR INVESTMENT AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION...Purchase Agreement • September 2nd, 2005 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 10.5 OPTION & LICENSE AGREEMENT 1. INTRODUCTION THIS AGREEMENT is between the UNIVERSITY OF SOUTHERN CALIFORNIA, (hereinafter USC) a California nonprofit corporation with its principal place of business at University Park, Los Angeles,...License Agreement • October 2nd, 2001 • Biokeys Pharmaceuticals Inc • California
SAVARA INC. SHARES OF COMMON STOCK (PAR VALUE $0.001 PER SHARE) SALES AGREEMENTSales Agreement • July 6th, 2021 • Savara Inc • Pharmaceutical preparations • New York
SAVARA INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with EVERCORE GROUP L.L.C. (the “Agent”) as follows:
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 3rd, 2010 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 2, 2010, between ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
EXHIBIT 4.29 THIS WARRANT HAS BEEN, AND THE SHARES OF COMMON STOCK WHICH MAY BE RECEIVED PURSUANT TO THE EXERCISE OF THIS WARRANT WILL BE, ACQUIRED SOLELY FOR INVESTMENT AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION...Adventrx Pharmaceuticals Inc • September 2nd, 2005 • Pharmaceutical preparations • California
MAST THERAPEUTICS, INC. SALES AGREEMENTSales Agreement • August 21st, 2015 • Mast Therapeutics, Inc. • Pharmaceutical preparations • New York
Mast Therapeutics, Inc. (the “Company”) confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as set forth below. This Agreement shall terminate and supersede that certain Sales Agreement, dated February 10, 2014, by and between the Company and Cowen (the “Prior Agreement”) as of the effective date of this Agreement and, upon entry into this Agreement, no further sales shall be made pursuant to the Prior Agreement.
21,250,000 SHARES of Common Stock and 10,625,000 WARRANTS OF ADVENTRX PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 14th, 2011 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • New York
The undersigned, ADVENTRX Pharmaceuticals, Inc., a company formed under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of the Company, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters”) named in Schedule I hereto for whom Rodman & Renshaw, LLC is acting as representative (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
EXHIBIT 4.20 STOCK SUBSCRIPTION AGREEMENT ADVENTRX Pharmaceuticals, Inc. 9948 Hibert Street, Suite 100 San Diego, CA 92131 This letter represents an agreement (this "AGREEMENT") between the undersigned (the "INVESTOR") and ADVENTRX Pharmaceuticals,...Stock Subscription Agreement • June 30th, 2004 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
50,000,000 Units Each Unit Consisting of One Share of Common Stock And One Warrant to Purchase 0.5 of a Share of Common Stock Mast Therapeutics, Inc. PURCHASE AGREEMENTPurchase Agreement • June 17th, 2013 • Mast Therapeutics, Inc. • Pharmaceutical preparations • New York
Mast Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 50,000,000 units (the “Firm Units”), each of which shall consist of (i) one (1) share of the Company’s Common Stock, $0.001 par value per share (the “Common Stock”) (such shares of Common Stock constituting a part of the Units, collectively the “Shares”), and (ii) one warrant to purchase 0.5 of a share of Common Stock (such warrants constituting a part of the Units, collectively the “Warrants”). The Company has also granted to the Underwriters an option to purchase up to 7,500,000 additional units on the terms and for the purposes set forth in Section 3 hereof (the “Option Units”). The shares of Common Stock issuable upon exercise of the Warrants are called the “Warrant Shares,” and the Warrant Shares, together with the Warrants and the Shares, are called the “Securities.” The Firm Units and any Option Units purcha
EXHIBIT 4.25 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION...Adventrx Pharmaceuticals Inc • August 26th, 2005 • Pharmaceutical preparations
Exhibit 4.3 COMMON STOCK AND WARRANT PURCHASE AGREEMENT This Common Stock and Warrant Purchase Agreement (this "AGREEMENT"), dated as of April 5, 2004 (the "AGREEMENT DATE"), is among ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the...Common Stock and Warrant Purchase Agreement • May 12th, 2004 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
STRICTLY CONFIDENTIAL Mr. Brian M. Culley Chief Business Officer Adventrx Pharmaceuticals Inc. 6725 Mesa Ridge Road Suite 100 San Diego, CA 92121 Dear Mr. Culley:Adventrx Pharmaceuticals Inc • January 4th, 2010 • Pharmaceutical preparations • New York
This letter (the “Agreement”) constitutes the agreement between Adventrx Pharmaceuticals Inc. (the “Company”) and Rodman & Renshaw, LLC (“Rodman”) that Rodman shall serve as the exclusive placement agent (the “Services”) for the Company, on a “best efforts” basis, in connection with the proposed offer and placement (the “Offering”) by the Company of approximately $15.0 million of securities of the Company (the “Securities”), including convertible preferred securities. The terms of the Offering and the Securities shall be mutually agreed upon by the Company and the investors and nothing herein implies that Rodman would have the power or authority to bind the Company or an obligation for the Company to issue any Securities or complete the Offering. The Company expressly acknowledges and agrees that Rodman’s obligations hereunder are on a reasonable best efforts basis only and that the execution of this Agreement does not constitute a commitment by Rodman to purchase the Securities and do
BY AND AMONGAgreement and Plan of Merger • October 2nd, 2001 • Biokeys Pharmaceuticals Inc • Delaware
EXHIBIT 4.21 THIS WARRANT HAS BEEN, AND THE SHARES OF COMMON STOCK WHICH MAY BE RECEIVED PURSUANT TO THE EXERCISE OF THIS WARRANT WILL BE, ACQUIRED SOLELY FOR INVESTMENT AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION...Adventrx Pharmaceuticals Inc • June 30th, 2004 • Pharmaceutical preparations • California
THIS WARRANT HAS BEEN, AND THE SHARES OF COMMON STOCK WHICH MAY BE RECEIVED PURSUANT TO THE EXERCISE OF THIS WARRANT WILL BE, ACQUIRED SOLELY FOR INVESTMENT AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION THEREOF. NEITHER...Warrant • April 13th, 2004 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
29,090,910 UNITS, EACH UNIT CONSISTING OF ONE SHARE OF COMMON STOCK AND ONE WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK, OF MAST THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 11th, 2016 • Mast Therapeutics, Inc. • Pharmaceutical preparations • New York
The undersigned, Mast Therapeutics, Inc., a company incorporated under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Mast Therapeutics, Inc. (the “Company”)), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and, each, an “Underwriter”) named in Schedule I hereto for which Roth Capital Partners, LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 7th, 2011 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 6, 2011, between ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 4.34 THIS WARRANT HAS BEEN, AND THE SHARES OF COMMON STOCK WHICH MAY BE RECEIVED PURSUANT TO THE EXERCISE OF THIS WARRANT WILL BE, ACQUIRED SOLELY FOR INVESTMENT AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION...Adventrx Pharmaceuticals Inc • August 26th, 2005 • Pharmaceutical preparations • California
